busulfan has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Overexpression of P-170 without amplification of MDR-1 was found in four of 11 patients with chronic phase CML at diagnosis, seven of 16 patients treated with busulfan or hydroxyurea in chronic phase and four of 15 patients in blast crisis." | 3.68 | The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia. ( Dowding, C; Goldman, J; Paulsen, W; Weide, R, 1990) |
| "The clinical course of 196 patients with chronic myelocytic leukemia (CML) was studied." | 2.67 | [Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. ( Anger, B; Carbonell, F; Ganser, A; Heimpel, H; Robertson, J; Schmeiser, T; Sokal, JE, 1990) |
| "Leukemic cells from many patients with acute myelogenous leukemia (AML) have surface receptors for CSFs and may proliferate in response to CSFs." | 2.40 | Cytokine therapy for hematological malignancies. ( Ezaki, K; Tsuzuki, M, 1997) |
| " Plasma concentrations of BU at steady state (C(SS)BU) during the dosing interval were measured for each patient." | 1.30 | Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. ( Anasetti, C; Appelbaum, FR; Bensinger, WI; Bowden, R; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Deeg, HJ; Doney, KC; Flowers, M; Gooley, T; Hansen, JA; Martin, PJ; McDonald, GB; Nash, R; Petersdorf, EW; Radich, J; Sanders, JE; Schoch, G; Slattery, JT; Soll, E; Stewart, P; Storb, R; Storer, B; Sullivan, KM; Thomas, ED; Witherspoon, RP, 1997) |
| "Fifty patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML) underwent allogeneic bone marrow transplantation between October 1988 and January 1997." | 1.30 | Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. ( Goto, S; Hirabayashi, N; Ishii, M; Mitsuma, A; Noda, N; Yuge, M, 1998) |
| "We proposed a new approach to treat chronic myelogenous leukemia using a combination of busulfan and Bestatin." | 1.29 | [Bestatin therapy of chronic myelogenous leukemia]. ( Saito, Y; Uzuka, Y, 1993) |
| "A case of chronic myelogenous leukemia (CML) of 10-year survival in described." | 1.28 | [Bone marrow aplasia without blast crisis in a case of CML of 10-year survival]. ( Abe, R; Ishibashi, T; Kariyone, S; Kimura, H; Matsuda, S; Shichishima, T; Shiga, Y; Uchida, T; Yokoyama, A; Yui, T, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 17 (73.91) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stagno, F | 2 |
| Vigneri, P | 2 |
| Del Fabro, V | 1 |
| Stella, S | 1 |
| Berretta, S | 1 |
| Massimino, M | 1 |
| Tirrò, E | 1 |
| Messina, A | 1 |
| Di Raimondo, F | 1 |
| Uberti, JP | 1 |
| Agovi, MA | 1 |
| Tarima, S | 1 |
| Haagenson, M | 1 |
| Gandham, S | 1 |
| Anasetti, C | 2 |
| Baker, KS | 1 |
| Bolwell, BJ | 1 |
| Bornhauser, M | 1 |
| Chan, KW | 1 |
| Copelan, E | 1 |
| Davies, SM | 1 |
| Finke, J | 1 |
| Hale, GA | 1 |
| Kollman, C | 1 |
| McCarthy, PL | 1 |
| Ratanatharathorn, V | 1 |
| Ringdén, O | 1 |
| Weisdorf, DJ | 1 |
| Rizzo, JD | 1 |
| Devergie, A | 1 |
| Blaise, D | 1 |
| Attal, M | 1 |
| Tigaud, JD | 1 |
| Jouet, JP | 1 |
| Vernant, JP | 1 |
| Bordigoni, P | 1 |
| Ifrah, N | 1 |
| Dauriac, C | 1 |
| Cahn, JY | 1 |
| Kiyoi, H | 1 |
| Fukutani, H | 1 |
| Yamauchi, T | 1 |
| Kubo, K | 1 |
| Ohno, R | 1 |
| Yamamori, S | 1 |
| Naoe, T | 1 |
| Hashimoto, T | 1 |
| Ohtaki, M | 1 |
| Ueoka, H | 1 |
| Munaka, M | 1 |
| Kuramoto, A | 1 |
| Kamada, N | 1 |
| Hehlmann, R | 2 |
| Heimpel, H | 3 |
| Kolb, HJ | 2 |
| Heinze, B | 2 |
| Hochhaus, A | 2 |
| Griesshammer, M | 2 |
| Pralle, H | 1 |
| Queisser, WP | 1 |
| Essers, U | 1 |
| Falge, C | 1 |
| Uzuka, Y | 1 |
| Saito, Y | 1 |
| Goldman, J | 2 |
| Slattery, JT | 1 |
| Clift, RA | 1 |
| Buckner, CD | 1 |
| Radich, J | 1 |
| Storer, B | 1 |
| Bensinger, WI | 1 |
| Soll, E | 1 |
| Bowden, R | 1 |
| Bryant, E | 1 |
| Chauncey, T | 1 |
| Deeg, HJ | 1 |
| Doney, KC | 1 |
| Flowers, M | 1 |
| Gooley, T | 1 |
| Hansen, JA | 1 |
| Martin, PJ | 1 |
| McDonald, GB | 1 |
| Nash, R | 1 |
| Petersdorf, EW | 1 |
| Sanders, JE | 1 |
| Schoch, G | 1 |
| Stewart, P | 1 |
| Storb, R | 1 |
| Sullivan, KM | 1 |
| Thomas, ED | 1 |
| Witherspoon, RP | 1 |
| Appelbaum, FR | 1 |
| Ezaki, K | 1 |
| Tsuzuki, M | 1 |
| Hirabayashi, N | 2 |
| Goto, S | 1 |
| Ishii, M | 1 |
| Yuge, M | 1 |
| Mitsuma, A | 1 |
| Noda, N | 1 |
| Bonini, A | 1 |
| Bandini, G | 1 |
| Rosti, G | 1 |
| Rondelli, D | 1 |
| Testoni, N | 1 |
| Remiddi, C | 1 |
| Motta, MR | 1 |
| Rizzi, S | 1 |
| Mangianti, S | 1 |
| Campanini, E | 1 |
| Zuffa, E | 1 |
| Tura, S | 1 |
| Singer, IO | 1 |
| Franklin, IM | 1 |
| Clark, RE | 1 |
| Chalmers, EA | 1 |
| Kelsey, SM | 2 |
| Newland, AC | 2 |
| Sproul, AM | 1 |
| Crotty, G | 1 |
| McCann, SR | 1 |
| Goldstone, AH | 1 |
| McBride, N | 1 |
| Hepplestone, A | 1 |
| Watson, W | 1 |
| Sharp, RA | 1 |
| Tansey, PJ | 1 |
| McBride, NC | 1 |
| Cavenagh, JD | 1 |
| Lillington, DM | 1 |
| Murrell, C | 1 |
| Ikegame, K | 1 |
| Takimoto, T | 1 |
| Takahashi, R | 1 |
| Murakami, M | 1 |
| Tamaki, H | 1 |
| Fujioka, T | 1 |
| Kawakami, M | 1 |
| Soma, T | 1 |
| Sugiyama, H | 1 |
| Ogawa, H | 1 |
| Matsuo, T | 1 |
| Tomonaga, M | 1 |
| Ozumba, BC | 1 |
| Obi, GO | 1 |
| Anger, B | 1 |
| Schmeiser, T | 1 |
| Robertson, J | 1 |
| Sokal, JE | 1 |
| Ganser, A | 1 |
| Carbonell, F | 1 |
| Nese, M | 1 |
| Weide, R | 1 |
| Dowding, C | 1 |
| Paulsen, W | 1 |
| Georgii, A | 1 |
| Hossfeld, DK | 1 |
| von Wussow, P | 1 |
| Diehl, V | 1 |
| Birnie, GD | 1 |
| MacKenzie, ED | 1 |
| Goyns, MH | 1 |
| Pollock, A | 1 |
| Shiga, Y | 1 |
| Yokoyama, A | 1 |
| Ishibashi, T | 1 |
| Shichishima, T | 1 |
| Abe, R | 1 |
| Yui, T | 1 |
| Kimura, H | 1 |
| Matsuda, S | 1 |
| Uchida, T | 1 |
| Kariyone, S | 1 |
3 reviews available for busulfan and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
ABC of clinical haematology. Chronic myeloid leukaemia.
Topics: Antineoplastic Agents, Alkylating; Busulfan; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positiv | 1997 |
Cytokine therapy for hematological malignancies.
Topics: Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Cytokines; Follow-Up Studies; Granulocyte | 1997 |
[Chemotherapy and radiation therapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl | 2001 |
8 trials available for busulfan and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM).
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Disease-Free Surv | 1995 |
Estimation of chronic phase duration in Ph-positive chronic myelocytic leukemia treated with busulfan: statistical analysis on Japanese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Busulfan; Child; Female; Humans; Japan; Leukemia, Myelog | 1994 |
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Topics: Adult; Busulfan; Female; Germany; Germany, West; Humans; Hydroxyurea; Immunologic Factors; Interfero | 1993 |
Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cytarabine; Disease Progression; Fo | 1998 |
Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cyclopho | 2000 |
[Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model].
Topics: Biomarkers, Tumor; Blast Crisis; Busulfan; Clinical Trials as Topic; Female; Follow-Up Studies; Huma | 1990 |
[Therapy of chronic myeloid leukemia with interferon, alone or combined. Preliminary experience].
Topics: Adolescent; Adult; Aged; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea; Immunolog | 1991 |
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
Topics: Busulfan; Female; Follow-Up Studies; Humans; Hydroxyurea; Interferon Type I; Leukemia, Myelogenous, | 1991 |
12 other studies available for busulfan and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Uncommon long-term survival in a patient with chronic myeloid leukemia.
Topics: Antineoplastic Agents; Busulfan; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Leukemia, My | 2009 |
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busu | 2011 |
Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crises after bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Blast Crisis; B | 1995 |
[Bestatin therapy of chronic myelogenous leukemia].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; | 1993 |
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cause of Death; Cyclophosphamide; Female; Graft Reject | 1997 |
Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busu | 1998 |
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclop | 1998 |
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation.
Topics: Adenoviridae Infections; Adenoviruses, Human; Antilymphocyte Serum; Bronchoalveolar Lavage Fluid; Bu | 2001 |
Successful pregnancy in a patient with chronic myeloid leukemia following therapy with cytotoxic drugs.
Topics: Acetaminophen; Adult; Busulfan; Diazepam; Drug Therapy, Combination; Female; Humans; Leukemia, Myelo | 1992 |
The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Busulfan; Drug Resistance; Ge | 1990 |
Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission.
Topics: Bone Marrow; Busulfan; Female; Follow-Up Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Po | 1990 |
[Bone marrow aplasia without blast crisis in a case of CML of 10-year survival].
Topics: Adult; Anemia, Aplastic; Blast Crisis; Bone Marrow; Busulfan; Humans; Leukemia, Myelogenous, Chronic | 1989 |